Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Gopal

Showing results (301-310 of 429) with videos related to

Pageof 43
Sort By:
Cancer Immunology Research|May 20, 2016
Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of RituximabGregory A Rufener, Oliver W Press, Philip Olsen, et al.
Practical Radiation Oncology|October 5, 2019
Impact of Double- or Triple-Hit Pathology on Rates and Durability of Radiation Therapy Response Among Patients With Relapsed or Refractory Large B-Cell LymphomaAileen Kim, Philip Stevenson, Ryan D Cassaday, et al.
Bone Marrow Transplantation|September 15, 2015
A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCTW I Bensinger, P S Becker, T A Gooley, et al.
Blood|March 9, 2013
Anti-CD45 radioimmunotherapy using (211)At with bone marrow transplantation prolongs survival in a disseminated murine leukemia modelJohnnie J Orozco, Tom Bäck, Aimee Kenoyer, et al.
American Journal of Hematology|January 22, 2019
Eligibility for CAR T-cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCLStephen D Smith, Prathima Reddy, Alexandra Sokolova, et al.
Plos One|December 3, 2014
Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia modelJohnnie J Orozco, Ethan R Balkin, Ted A Gooley, et al.
Blood Advances|October 14, 2021
Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphomaVictor A Chow, Ryan D Cassaday, Theodore A Gooley, et al.
Blood|September 30, 2009
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndromeJohn M Pagel, Theodore A Gooley, Joseph Rajendran, et al.
Haematologica|October 5, 2019
Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasiaPhuong Vo, Ted A Gooley, Joseph G Rajendran, et al.
Journal of Clinical and Experimental Hepatology|January 27, 2025
Prevalence of Transaminitis and Metabolic Dysfunction-Associated Steatotic Liver Disease Among Young Indian Adults-A Population-Based StudyAbilash Nair, Jabbar Puthiyaveettil Khadar, Archana Mohan Preetha, et al.
Pageof 43

Showing results (301-310 of 429) with videos related to

Sort By:
Pageof 43
Cancer Immunology Research|May 20, 2016
Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of RituximabGregory A Rufener, Oliver W Press, Philip Olsen, et al.
Practical Radiation Oncology|October 5, 2019
Impact of Double- or Triple-Hit Pathology on Rates and Durability of Radiation Therapy Response Among Patients With Relapsed or Refractory Large B-Cell LymphomaAileen Kim, Philip Stevenson, Ryan D Cassaday, et al.
Bone Marrow Transplantation|September 15, 2015
A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCTW I Bensinger, P S Becker, T A Gooley, et al.
Blood|March 9, 2013
Anti-CD45 radioimmunotherapy using (211)At with bone marrow transplantation prolongs survival in a disseminated murine leukemia modelJohnnie J Orozco, Tom Bäck, Aimee Kenoyer, et al.
American Journal of Hematology|January 22, 2019
Eligibility for CAR T-cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCLStephen D Smith, Prathima Reddy, Alexandra Sokolova, et al.
Plos One|December 3, 2014
Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia modelJohnnie J Orozco, Ethan R Balkin, Ted A Gooley, et al.
Blood Advances|October 14, 2021
Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphomaVictor A Chow, Ryan D Cassaday, Theodore A Gooley, et al.
Blood|September 30, 2009
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndromeJohn M Pagel, Theodore A Gooley, Joseph Rajendran, et al.
Haematologica|October 5, 2019
Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasiaPhuong Vo, Ted A Gooley, Joseph G Rajendran, et al.
Journal of Clinical and Experimental Hepatology|January 27, 2025
Prevalence of Transaminitis and Metabolic Dysfunction-Associated Steatotic Liver Disease Among Young Indian Adults-A Population-Based StudyAbilash Nair, Jabbar Puthiyaveettil Khadar, Archana Mohan Preetha, et al.
Pageof 43